The 2024-25 NHL season hit its midway point on Thursday. It's a perfect time to take a quick tour of the league. Here's one ...

BMO Capital lowered the firm’s price target on Intellia Therapeutics (NTLA) to $50 from $70 and keeps an Outperform rating on the shares. The ...

Fintel reports that on January 9, 2025, RBC Capital upgraded their outlook for Bank of Montreal (NYSE:BMO) from Sector ...

In a report released on January 7, Josh Wolfson from RBC Capital maintained a Buy rating on Osisko Gold Royalties (OR – Research Report), with ...

Bank of Montreal closed C$5.91 short of its 52-week high of C$147.54, which the company reached on December 6th.